Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00381121 · ClinicalTrials.gov registry record
University of Michigan "Nephrology Research BioBank"
A clinical trial of Chronic Kidney Disease, sponsored by University of Michigan.
- Recruiting
- Registry status
- 420
- Enrollment target
- 1
- Study location
NCT00381121 is a study of Chronic Kidney Disease that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 420 participants, below the 3,203-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00381121, a study of Chronic Kidney Disease, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- 420 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to create a Nephrology Tissue Biobank enabling the study of kidney disease from the perspectives of epidemiology, genetics and molecular biology.
Conditions Studied
Study Locations (1)
Michigan
- University of Michigan Health System - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2006-09 |
| Est. Completion | 2030-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00381121
The ClinicalTrials.gov registry entry for NCT00381121 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,203-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (87% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00381121 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT00381121 about?
NCT00381121 is a clinical study titled "University of Michigan "Nephrology Research BioBank"". The purpose of the study is to create a Nephrology Tissue Biobank enabling the study of kidney disease from the perspectives of epidemiology, genetics and molecular biology.
What is the current status of trial NCT00381121?
This trial is currently recruiting. The enrollment target is 420 participants. The study started on 2006-09. Estimated completion is 2030-08.
What conditions does trial NCT00381121 study?
This clinical trial studies the following conditions: Chronic Kidney Disease.
Who is sponsoring clinical trial NCT00381121?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00381121 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
RECRUITING · Phase 2
-
Patient-driven Management of BP in CKD
RECRUITING · Phase 3
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Safety of Short-course of NSAIDs in Pediatric Patients With CKD
RECRUITING · Phase 4
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.